[Congressional Record (Bound Edition), Volume 159 (2013), Part 11]
[Senate]
[Pages 16813-16814]
[From the U.S. Government Publishing Office, www.gpo.gov]




            DRUG QUALITY AND SECURITY ACT--MOTION TO PROCEED

  Mr. REID. Is the motion to proceed to H.R. 3204 now pending?
  The PRESIDING OFFICER. The motion to proceed to H.R. 3204 is pending.
  Mr. REID. I have a cloture motion at the desk.
  The PRESIDING OFFICER. The cloture motion having been presented under 
rule XXII, the Chair directs the clerk to read the motion.
  The assistant legislative clerk read as follows:

                             Cloture Motion

       We, the undersigned Senators, in accordance with the 
     provisions of rule XXII of the Standing Rules of the Senate, 
     hereby move to bring to a close debate on the motion to 
     proceed to Calendar No. 236, H.R. 3204, an Act

[[Page 16814]]

     to amend the Federal Food, Drug, and Cosmetic Act with 
     respect to human drug compounding and drug supply chain 
     security, and for other purposes.
         Harry Reid, Tom Harkin, Patrick J. Leahy, Tom Udall, Mark 
           Begich, Brian Schatz, Al Franken, Barbara Boxer, 
           Richard J. Durbin, Christopher A. Coons, Debbie 
           Stabenow, Benjamin L. Cardin, Sheldon Whitehouse, Patty 
           Murray, Barbara Mikulski, Kirsten E. Gillibrand, Jeff 
           Merkley.

  Mr. REID. Mr. President, I ask unanimous consent that the mandatory 
quorum under rule XXII be waived.
  The PRESIDING OFFICER. Without objection, it is so ordered.

                          ____________________